Literature DB >> 9284715

Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment.

B Kriström1, C Jansson, S Rosberg, K Albertsson-Wikland.   

Abstract

The purpose of the study was to evaluate the relationship between the 1-yr (n = 193) and 2-yr (n = 128) growth response and the individual serum concentrations of insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) before and during GH treatment. Our study group of prepubertal short children had from very low to high GH secretory capacity, estimated during an arginine-insulin tolerance test, and the ages ranged from 3-15 yr at the start of treatment. Their serum levels of IGF-I and IGFBP-3 were low before treatment compared to those in an age-related reference group of prepubertal children and increased significantly from the start to 1 month of GH treatment. The mean increase in height SD score was 0.80 SD score after 1 yr of GH treatment and 1.26 SD score after 2 yr, with a wide range. In univariate analyses the highest correlation coefficients to the 2-yr growth response were found to be vs. the following variables from the start of treatment: IGF-I SD score (r = -0.49), log maximum GH concentration (log GHmax) during the arginine-insulin tolerance test (r = -0.47), difference between the height SD score of the individual child and the midparental height SD score (diffSD score; r = -0.45), IGFBP-3 SD score (r = -0.39), age (r = -0.30), short term change in IGFBP-3 SD score (r = 0.37), and IGF-I SD score (r = 0.34). In multivariate stepwise regression analysis, 41% of the variation in the 2-yr growth response could be explained by IGF-I SD score or log GHmax together with age at the start of treatment, weight SD score at 1 yr of age, and diffSD score. When both IGF-I SD score and GHmax were included and when the short term changes in IGF-I SD score were added, 46% and 58% of the variation, respectively, could be explained. The regression algorithms using different combinations of variables and their corresponding prediction intervals are also presented.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284715     DOI: 10.1210/jcem.82.9.4234

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

1.  Predicting response to growth hormone treatment.

Authors:  Leena Patel; Peter E Clayton
Journal:  Indian J Pediatr       Date:  2011-11-22       Impact factor: 1.967

2.  Prediction of response to growth hormone treatment in pre-pubertal children with growth hormone deficiency.

Authors:  D Valle; E Bartolotta; M Caruso; C De Sanctis; A Falorni; G Saggese; A M Pasquino; L Tauchmanova; A Cicognani
Journal:  J Endocrinol Invest       Date:  2010-10-27       Impact factor: 4.256

Review 3.  Growth hormone - past, present and future.

Authors:  Michael B Ranke; Jan M Wit
Journal:  Nat Rev Endocrinol       Date:  2018-03-16       Impact factor: 43.330

4.  A technique of mRNA extraction and labeling from circulating lymphocytes of children treated with growth hormone replacement therapy for microarray analysis.

Authors:  M Camilot; F Teofoli; S Longobardi; A Gandini; C Lievore; S Lauriola; L Tatò
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

Review 5.  Growth hormone treatment in children: review of safety and efficacy.

Authors:  Mark Harris; Paul L Hofman; Wayne S Cutfield
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

6.  Development of a Predictive Enrichment Marker for the Oral GH Secretagogue LUM-201 in Pediatric Growth Hormone Deficiency.

Authors:  George M Bright; Minh-Ha T Do; John C McKew; Werner F Blum; Michael O Thorner
Journal:  J Endocr Soc       Date:  2021-02-25

Review 7.  IGF-I measurements in the monitoring of GH therapy.

Authors:  Claire E Higham; Andreas Jostel; Peter J Trainer
Journal:  Pituitary       Date:  2007       Impact factor: 3.599

8.  The variability of responses to growth hormone therapy in children with short stature.

Authors:  Martin O Savage; Peter Bang
Journal:  Indian J Endocrinol Metab       Date:  2012-12

9.  The first-year growth response to growth hormone treatment predicts the long-term prepubertal growth response in children.

Authors:  Berit Kriström; Jovanna Dahlgren; Aimon Niklasson; Andreas F M Nierop; Kerstin Albertsson-Wikland
Journal:  BMC Med Inform Decis Mak       Date:  2009-01-12       Impact factor: 2.796

10.  Models predicting the growth response to growth hormone treatment in short children independent of GH status, birth size and gestational age.

Authors:  Jovanna Dahlgren; Berit Kriström; Aimon Niklasson; Andreas F M Nierop; Sten Rosberg; Kerstin Albertsson-Wikland
Journal:  BMC Med Inform Decis Mak       Date:  2007-12-12       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.